文献速递妇科

COVID-19 时代的根治性子宫切除术病例量与宫颈癌治疗:国家癌症研究所指定综合癌症中心的多中心分析

Radical hysterectomy case volume and cervical cancer treatment in the era of COVID-19: A multi-site analysis of National Cancer Institute-designated Comprehensive Cancer Centers.
PubMed 文献 · Gynecol Oncol · 2023-11-07

多中心回顾性队列研究比较 COVID-19 疫情前后浸润性宫颈癌的根治性子宫切除术病例量、分期及活检至治疗时间。疫情及恢复期每月平均根治性子宫切除术病例量从 7 例降至 5 例,I 期比例从 49.5% 降至 40.7%,II-IV 期比例从 50.1% 升至 58.8%,初治手术比例及 6 周内手术比例均下降。

要点

  • 疫情及恢复期每月平均根治性子宫切除术病例量从 7 例降至 5 例(p=0.001)。
  • I 期诊断比例从 49.5% 降至 40.7%,II-IV 期比例从 50.1% 升至 58.8%。
  • 初治手术比例从 46.7% 降至 38.3%,6 周内手术比例从 38.9% 降至 27.4%。

核心结论

  • COVID-19 疫情后全美观察到根治性子宫切除术病例量降低、宫颈癌分期向更高期别偏移以及手术治疗延迟。
  • 手术量下降可能源于早期病变检出减少或其他因素。

研究设计与样本

  • 多机构回顾性队列研究,在 6 个地理分布广泛的大型国家癌症研究所指定癌症中心开展。
  • 纳入 2018年3月1日至2021年12月31日期间新诊断浸润性宫颈癌并接受治疗的患者,共 561 例。
  • 按首次妇科肿瘤就诊日期分为疫情前组(2018年3月1日至2020年2月28日)和疫情及恢复组(2020年4月1日至2021年12月31日)。
  • 主要结局为每月根治性子宫切除术总病例量,次要结局为诊断时分期和诊断至治疗时间。
  • 统计分析采用卡方检验和两样本 t 检验。

主要发现

  • 疫情前组与疫情及恢复组在年龄、种族、民族、吸烟状态和体重指数方面相似。
  • 疫情及恢复期每月平均根治性子宫切除术病例量从 7 例(SD 2.8)降至 5 例(SD 2.0)(p=0.001)。
  • I 期诊断比例从 278/561(49.5%)降至 155/381(40.7%),II-IV 期诊断比例从 281/561(50.1%)升至 224/381(58.8%)。
  • 初治手术比例疫情及恢复组为 38.3%,疫情前组为 46.7%(p=0.013)。
  • 接受手术的患者中,诊断后 6 周内手术比例疫情及恢复组为 27.4%,疫情前组为 38.9%(p=0.025)。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To compare radical hysterectomy case volume, cancer stage, and biopsy-to-treatment time of invasive cervical cancer diagnosed before and after onset of the COVID-19 pandemic. METHODS: In a multi-institution retrospective cohort study conducted at 6 large, geographically diverse National Cancer Institute-designated cancer centers, patients treated for newly diagnosed invasive cervical cancer were classified into 2 temporal cohorts based on date of first gynecologic oncology encounter: (1) Pre-Pandemic: 3/1/2018-2/28/2020; (2) Pandemic & Recovery: 4/1/2020-12/31/2021. The primary outcome was total monthly radical hysterectomy case volume. Secondary outcomes were stage at diagnosis and diagnosis-to-treatment time. Statistical analyses used chi-squared and two sample t-tests. RESULTS: Between 3/1/2018-12/31/2021, 561 patients were diagnosed with cervical cancer. The Pre-Pandemic and Pandemic & Recovery cohorts had similar age, race, ethnicity, smoking status, and Body Mass Index (BMI). During Pandemic & Recovery, the mean monthly radical hysterectomy case volume decreased from 7[SD 2.8] to 5[SD 2.0] (p = 0.001), the proportion of patients diagnosed with Stage I disease dropped from 278/561 (49.5%) to 155/381 (40.7%), and diagnosis of stage II-IV disease increased from 281/561 (50.1%) to 224/381 (58.8%). Primary surgical management was less frequent (38.3% Pandemic & Recovery versus 46.7% Pre-Pandemic, p = 0.013) and fewer surgically-treated patients received surgery within 6 weeks of diagnosis (27.4% versus 38.9%; p = 0.025). CONCLUSIONS: Lower radical hysterectomy case volume, a shift to higher cervical cancer stage, and delay in surgical therapy were observed across the United States following the COVID-19 outbreak. Decreased surgical volume may result from lower detection of early-stage disease or other factors.

来源:Gynecol Oncol,查看原文。版权归原作者所有。

引用

  1. Wickenheisser NE, Dillon M, Broadwater G, et al. Radical hysterectomy case volume and cervical cancer treatment in the era of COVID-19: A multi-site analysis of National Cancer Institute-designated Comprehensive Cancer Centers. Gynecol Oncol. 2023. PMID: 37944328. doi:10.1016/j.ygyno.2023.10.010

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。